The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.
本发明提供了化合物,包括这些化合物的制药组合物以及使用这些化合物治疗或预防与
过氧化物酶体增殖物激活受体(
PPAR)家族活性相关的疾病或疾病的方法。